Assessment on implantable defibrillators and the evidence for primary prevention of sudden cardiac death
Most studies excluded older adults over 70 to 80 years. SCD occurred in 4 to 13 percent of control patients during the 2 to 5 years after randomization. A high strength of evidence shows early (in-hospital) adverse event rates of approximately 3 percent and serious adverse event rates of approximate...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, Maryland
AHRQ, Technology Assessment Program
June 26, 2013, 2013
|
| Series: | Technology assessment report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references